Medicare Enrolled
Dr. David Greeley, MD
Hospitalist Physician · Spokane, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Greeley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greeley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Greeley
Dr. David Greeley is a hospitalist physician in Spokane, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Greeley performed 40,883 Medicare services across 900 unique beneficiaries.
Between the years covered by Open Payments, Dr. Greeley received a total of $35,096 from 71 pharmaceutical and/or device companies across 874 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Greeley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in WA
$35,096 industry payments
Medicare Practice Summary
Medicare Utilization ↗40,883
Medicare services
Top 0% in WA for hospitalist physician
900
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,152 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
26,600 | $5 | $12 |
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
12,245 | $4 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
723 | $89 | $237 |
| Magnetic field treatment to stimulate brain nerve cells A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment. |
643 | $93 | $738 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
141 | $131 | $322 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
133 | $122 | $335 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
100 | $112 | $306 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
78 | $156 | $309 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 74 | $64 | $159 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
52 | $28 | $70 |
| New patient office visit, complex (60-74 min) | 39 | $172 | $433 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $59 | $163 |
| Magnetic field treatment to stimulate brain nerve cells, initial delivery A procedure that uses a magnetic field to stimulate nerve cells in the brain. This code covers the initial delivery and management of the treatment. |
19 | $175 | $1,052 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$35,096
Total received (2018-2024)
Avg $5,014/year across 7 years
Top 1% in WA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
874
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,897 (53.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,858 (45.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,262
2023
$10,922
2022
$8,618
2021
$6,358
2020
$2,285
2019
$2,153
2018
$1,498
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merz Pharmaceuticals, LLC
$547
ABBVIE INC.
$536
Eisai Inc.
$358
Lilly USA, LLC
$339
Teva Pharmaceuticals USA, Inc.
$238
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$202
Celgene Corporation
$131
Biogen, Inc.
$93
Amneal Pharmaceuticals LLC
$92
REVANCE THERAPEUTICS, INC.
$87
MDD US Operations, LLC
$81
Ipsen Biopharmaceuticals, Inc
$76
Axsome Therapeutics, Inc.
$70
Lundbeck LLC
$63
Otsuka America Pharmaceutical, Inc.
$56
PFIZER INC.
$54
Neurocrine Biosciences, Inc.
$52
UCB, Inc.
$39
Janssen Pharmaceuticals, Inc
$34
Supernus Pharmaceuticals, Inc.
$34
SK Life Science, Inc.
$22
Xeris Pharmaceuticals, Inc.
$21
ACADIA Pharmaceuticals Inc
$20
Cala Health, Inc.
$17
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$9,135
Biogen, Inc.
$7,011
EISAI INC.
$3,270
Teva Pharmaceuticals USA, Inc.
$1,545
Lilly USA, LLC
$1,250
ABBVIE INC.
$1,235
Merz Pharmaceuticals, LLC
$1,168
Neuronetics, Inc.
$1,021
Allergan, Inc.
$673
Neurocrine Biosciences, Inc.
$647
Amgen Inc.
$647
ACADIA Pharmaceuticals Inc
$462
Merz North America, Inc.
$406
Celgene Corporation
$403
Acorda Therapeutics, Inc
$364
AbbVie Inc.
$360
Genentech USA, Inc.
$337
Lundbeck LLC
$321
Amneal Pharmaceuticals LLC
$301
Novartis Pharmaceuticals Corporation
$280
Janssen Pharmaceuticals, Inc
$271
Sunovion Pharmaceuticals Inc.
$225
Alexion Pharmaceuticals, Inc.
$225
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$202
Biohaven Pharmaceuticals, Inc.
$201
Otsuka America Pharmaceutical, Inc.
$197
IMPEL PHARMACEUTICALS INC.
$196
Ipsen Biopharmaceuticals, Inc
$190
Allergan Inc.
$189
ARGENX US, INC.
$136
Upsher-Smith Laboratories LLC
$129
E.R. Squibb & Sons, L.L.C.
$123
Boston Scientific Corporation
$118
MERZ NORTH AMERICA, INC.
$110
GENZYME CORPORATION
$105
MDD US Operations, LLC
$102
PFIZER INC.
$100
Supernus Pharmaceuticals, Inc.
$97
ITI, Inc.
$93
REVANCE THERAPEUTICS, INC.
$87
Genentech, Inc.
$82
CSL Behring
$82
UPSHER-SMITH LABORATORIES LLC
$71
Axsome Therapeutics, Inc.
$70
Xeris Pharmaceuticals, Inc.
$68
Biohaven Pharmaceutical Holding Company Ltd.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$55
Kyowa Kirin, Inc.
$48
BANNER LIFE SCIENCES, LLC
$47
AbbVie, Inc.
$41
US WorldMeds, LLC
$40
UCB, Inc.
$39
Avanir Pharmaceuticals, Inc.
$37
Cala Health, Inc.
$36
GE Healthcare
$35
Octapharma USA, Inc.
$34
Impax Laboratories, Inc.
$30
Strongbridge US INC.
$28
BOSTON SCIENTIFIC CORPORATION
$25
Adamas Pharmaceuticals, Inc.
$24
SK Life Science, Inc.
$22
GE HealthCare
$21
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
Banner Life Sciences, LLC
$21
Alkermes, Inc.
$21
Exeltis, USA Inc.
$20
Mallinckrodt LLC
$19
Horizon Therapeutics plc
$18
GE HEALTHCARE
$17
Medtronic USA, Inc.
$16
Kedrion Biopharma, Inc.
$12
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Albuked · Austedo XR · Auvelity · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Bionic Navigator · CALA KIQ · CALA TRIO · CAPLYTA · CREXONT · DAXXIFY · DAYBUE · Duopa · Dysport · EMGALITY · Fycompa · GAMMAGARD · GENERAL - DBS · GOCOVRI · General - DBS · Gocovri · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEQEMBI · LYBALVI · Leqembi · Lucemyra/Lofexidine · MAYZENT · MYOBLOC · NEUROSTAR TMS THERAPY · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · Ocrevus · Ongentys · PLEGRIDY · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qelbree · REXULTI · REYVOW · RYTARY · Rystiggo · SOLIRIS · SPRAVATO · Soliris · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VRAYLAR · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · XEOMIN · Xeomin · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for hospitalist physician in WA.
Geographic Context
Hospitalist physicians within 10 mi
35
Per 100K population
6.4
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Greeley is a mixed practice specialist, with above-average Medicare volume (top 0% in WA), with consulting-driven industry engagement in the top 1% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Greeley experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Greeley performed 26,600 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Greeley receive payments from pharmaceutical companies?
Yes. Dr. Greeley received a total of $35,096 from 71 companies across 874 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greeley's costs compare to other hospitalist physicians in Spokane?
Dr. Greeley's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greeley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in Spokane
Browse hospitalist physicians in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in WA
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in WA
Which WA hospitalist physicians receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
EISAI INC. Payments to Doctors
See all physicians who received payments from EISAI INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology